Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) granted priority review for two supplemental Biologics License ...

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...

Start-up business Coral has raised $12.5 million of seed funding as it rolls out new automation tools designed to help ...

Eugene Lim, who inspired thousands in the running community, was diagnosed with stage 4 bladder cancer in 2024 ...

The Evoc Hydro Pro 3 is marketed for mountain bikers and gravel riders. In terms of capacity, it sits in the middle of Evoc’s ...

Engaging in moderate to vigorous physical activity, even below recommended levels, can significantly improve cancer survival ...

It is springtime again and many of us are back outside hitting the walking paths and biking trails. It might be a good time to come clean about my little ...

Deion Sanders’ persona has always seemed connected to this idea — when the cameras are rolling, he’s the bright light in the ...

ImmunityBio (IBRX) has moved back into focus after releasing preliminary Q1 2026 net product revenue of about US$44.2 million, with management tying the performance to ANKTIVA uptake, broader ...

New Illicit Tobacco Ladder shows which states are falling behind Today, the Australian Council on Smoking and Health (ACOSH) has released a new ...

What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns ...